UBI Pharma was established on July 31, 2014 as a spin-off company from United Biomedical, Inc., Asia. UBI Pharma specializes in developing and manufacturing fusion protein drugs and formulations of small molecule pharmaceuticals.
UBI Pharma is dedicated to developing biobetters and specialty injectables on exclusively owned long-acting protein drug platforms, such as fusion proteoglycan, fusion single Fc chain, and new formulations. UBI Pharma has the US FDA registered and inspected facility ... More